CDH2 and melanoma: Our study revisits the same antigens, but to potentially improve on melanoma CTC isolation, tested three additional antibodies against cell surface proteins either commonly upregulated during melanoma progression (N-cadherin), or promising antigens with common membrane staining of melanoma cells (KBA.62, LHM3).